317 related articles for article (PubMed ID: 24687070)
1. Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.
Hartung DM; Zarin DA; Guise JM; McDonagh M; Paynter R; Helfand M
Ann Intern Med; 2014 Apr; 160(7):477-83. PubMed ID: 24687070
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles.
Tang E; Ravaud P; Riveros C; Perrodeau E; Dechartres A
BMC Med; 2015 Aug; 13():189. PubMed ID: 26269118
[TBL] [Abstract][Full Text] [Related]
3. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
[TBL] [Abstract][Full Text] [Related]
4. ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
Schwartz LM; Woloshin S; Zheng E; Tse T; Zarin DA
Ann Intern Med; 2016 Sep; 165(6):421-30. PubMed ID: 27294570
[TBL] [Abstract][Full Text] [Related]
5. Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?
Lv JW; Chen YP; Zhou GQ; Liu X; Guo Y; Mao YP; Ma J; Sun Y
J Natl Compr Canc Netw; 2017 Nov; 15(11):1363-1371. PubMed ID: 29118228
[No Abstract] [Full Text] [Related]
6. Reporting discrepancies between the clinicaltrials.gov results database and peer-reviewed publications.
Becker JE; Ross JS
Ann Intern Med; 2014 Nov; 161(10):760. PubMed ID: 25402518
[No Abstract] [Full Text] [Related]
7. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.
Riveros C; Dechartres A; Perrodeau E; Haneef R; Boutron I; Ravaud P
PLoS Med; 2013 Dec; 10(12):e1001566; discussion e1001566. PubMed ID: 24311990
[TBL] [Abstract][Full Text] [Related]
8. Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study.
Hughes S; Cohen D; Jaggi R
BMJ Open; 2014 Jul; 4(7):e005535. PubMed ID: 25009136
[TBL] [Abstract][Full Text] [Related]
9. Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications.
Wong EK; Lachance CC; Page MJ; Watt J; Veroniki A; Straus SE; Tricco AC
BMJ Open; 2019 Sep; 9(9):e031138. PubMed ID: 31492792
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reporting phase III randomized controlled trials of antibiotic treatment for common bacterial infections in ClinicalTrials.gov and matched publications.
Shepshelovich D; Yelin D; Gafter-Gvili A; Goldman S; Avni T; Yahav D
Clin Microbiol Infect; 2018 Nov; 24(11):1211.e9-1211.e14. PubMed ID: 29454846
[TBL] [Abstract][Full Text] [Related]
11. Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study.
Paladin I; Pranić SM
BMC Med Res Methodol; 2022 Oct; 22(1):262. PubMed ID: 36199040
[TBL] [Abstract][Full Text] [Related]
12. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
13. Haphazard reporting of deaths in clinical trials: a review of cases of ClinicalTrials.gov records and matched publications-a cross-sectional study.
Earley A; Lau J; Uhlig K
BMJ Open; 2013 Jan; 3(1):. PubMed ID: 23335556
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Consistency Between Peer-Reviewed Publications and Clinical Trial Registries.
Sun LW; Lee DJ; Collins JA; Carll TC; Ramahi K; Sandy SJ; Unteriner JG; Weinberg DV
JAMA Ophthalmol; 2019 May; 137(5):552-556. PubMed ID: 30946427
[TBL] [Abstract][Full Text] [Related]
15. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM
PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis.
Pradhan R; Singh S
Drug Saf; 2018 Sep; 41(9):849-857. PubMed ID: 29644579
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials on drug-drug interactions registered in ClinicalTrials.gov reported incongruent safety data in published articles: an observational study.
Jurić D; Pranić S; Tokalić R; Milat AM; Mudnić I; Pavličević I; Marušić A
J Clin Epidemiol; 2018 Dec; 104():35-45. PubMed ID: 30081071
[TBL] [Abstract][Full Text] [Related]
18. Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials.
Perlmutter AS; Tran VT; Dechartres A; Ravaud P
Ann Oncol; 2017 Apr; 28(4):688-695. PubMed ID: 28011448
[TBL] [Abstract][Full Text] [Related]
19. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
[TBL] [Abstract][Full Text] [Related]
20. Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis.
Chen KY; Borglund EM; Postema EC; Dunn AG; Bourgeois FT
Clin Trials; 2022 Aug; 19(4):442-451. PubMed ID: 35482320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
